For generations, inequality has been measured by wealth, education, and opportunity. But biotechnology is changing the meaning of inheritance itself. Advances in gene editing, embryo selection, CRISPR, and personalized medicine raise a profound possibility: the wealthiest families may one day pass down not only financial advantages, but biological ones. If health, longevity, intelligence, or other traits become increasingly selectable, inequality may no longer end with income—it could become embedded in future generations. This conversation explores whether human enhancement represents medicine's next breakthrough or the beginning of a new genetic class system. Together, we'll examine the ethics of designer babies, inherited health, parental responsibility, disability, eugenics, and whether society should place limits on redesigning human potential before inequality becomes written into our DNA.
Gene editing, embryo selection, CRISPR, longevity medicine, cognitive enhancement, and personalized healthcare raise a profound possibility: the wealthiest families may eventually pass down not only financial advantages, but biological ones.

If intelligence, disease resistance, lifespan, athleticism, or other traits become increasingly selectable, inequality may no longer be measured only in income. It could become embedded into future generations.

This conversation explores whether human enhancement represents the beginning of a new genetic class system. Along the way, participants will wrestle with questions of fairness, freedom, parental responsibility, eugenics, disability, and whether society should place limits on redesigning human potential.